NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+0.68%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$788M
AUM Growth
-$35.9M
(-4.4%)
Cap. Flow
+$36.1M
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
45.27%
Holding
137
New
21
Increased
29
Reduced
37
Closed
17
Top Buys
| 1 |
Assertio
ASRT
|
$12M |
| 2 |
America's Car Mart
CRMT
|
$11.4M |
| 3 |
Zevra Therapeutics
ZVRA
|
$11.1M |
| 4 |
Peloton Interactive
PTON
|
$9.05M |
| 5 |
Neuropace
NPCE
|
$7.74M |
Top Sells
| 1 |
The Bancorp
TBBK
|
$13.2M |
| 2 |
AUTL
Autolus Therapeutics
AUTL
|
$10.2M |
| 3 |
Pathward Financial
CASH
|
$7.8M |
| 4 |
Soleno Therapeutics
SLNO
|
$7.6M |
| 5 |
MediaAlpha
MAX
|
$7.51M |
Sector Composition
| 1 | Healthcare | 53.65% |
| 2 | Consumer Discretionary | 13.83% |
| 3 | Financials | 9.32% |
| 4 | Communication Services | 8.18% |
| 5 | Technology | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
C4 Therapeutics
CCCC
$194M
| $1.86M | 0.16% |
1,000,000
| – | – |
|
77
Fortress Biotech
FBIO
$110M
| $1.75M | 0.15% |
401,214
-24,833
| -6% | -$108K |
|
78
Scully Royalty
SRL
$80.8M
| $1.69M | 0.14% |
298,491
-5,245
| -2% | -$29.7K |
|
79
Jasper Therapeutics
JSPR
$44.2M
| $1.68M | 0.14% |
240,290
-7,498
| -3% | -$52.5K |
|
80
Anebulo Pharmaceuticals
ANEB
$97.8M
| $1.56M | 0.13% |
511,073
| – | – |
|
|
AAN
81
DELISTED
The Aaron's Company, Inc.
AAN
| $1.45M | 0.12% |
138,572
| – | – |
|
|
JBIO
82
Jade Biosciences, Inc. Common Stock
JBIO
$254M
| $1.29M | 0.11% |
2,714
| – | – |
|
83
TG Therapeutics
TGTX
$5.11B
| $1.25M | 0.11% |
+150,000
| New | +$1.25M |
|
84
Neurogene
NGNE
$285M
| $1.18M | 0.1% |
+75,000
| New | +$1.18M |
|
85
NeuroOne Medical Technologies
NMTC
$39.6M
| $1.11M | 0.1% |
+1,250,000
| New | +$1.11M |
|
86
Rezolute
RZLT
$696M
| $1.02M | 0.09% |
769,606
| – | – |
|
87
Journey Medical
DERM
$184M
| $955K | 0.08% |
348,663
+169,957
| +95% | +$466K |
|
|
88
The Bancorp
TBBK
$3.49B
| $859K | 0.07% |
24,896
-383,050
| -94% | -$13.2M |
|
89
SPAR Group
SGRP
$28.2M
| $847K | 0.07% |
879,189
+121,157
| +16% | +$117K |
|
|
ACER
90
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $748K | 0.06% |
918,349
-218,067
| -19% | -$178K |
|
91
Talphera
TLPH
$11.3M
| $680K | 0.06% |
+1,173,015
| New | +$680K |
|
|
SCTL
92
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $586K | 0.05% |
+1,250,000
| New | +$586K |
|
93
Sensus Healthcare
SRTS
$53.1M
| $513K | 0.04% |
185,048
| – | – |
|
94
Instil Bio
TIL
$213M
| $428K | 0.04% |
+50,000
| New | +$428K |
|
|
APTO
95
DELISTED
Aptose Biosciences, Inc.
APTO
| $382K | 0.03% |
4,549
-325
| -7% | -$27.3K |
|
|
LADR
96
Ladder Capital
LADR
$1.51B
| $278K | 0.02% |
27,073
| – | – |
|
97
Exagen
XGN
$213M
| $258K | 0.02% |
106,769
-15,125
| -12% | -$36.6K |
|
98
Elicio Therapeutics
ELTX
$188M
| $254K | 0.02% |
30,000
-64,939
| -68% | -$549K |
|
99
ADC Therapeutics
ADCT
$398M
| $231K | 0.02% |
257,162
-582,838
| -69% | -$523K |
|
100
Transact Technologies
TACT
$45.7M
| $200K | 0.02% |
31,108
-8,392
| -21% | -$53.9K |
|